featured
Efficacy and Safety of Antithrombotic Strategies Within and Beyond 12 Months in Patients With Established CAD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Heart Journal: Cardiovascular Pharmacotherapy
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease. Two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC) and European Association of Preventive Cardiology (EAPC)
Eur Heart J Cardiovasc Pharmacother 2023 Mar 03;[EPub Ahead of Print], EP Navarese, A Landi, A Oliva, R Piccolo, V Aboyans, D Angiolillo, D Atar, D Capodanno, KAA Fox, S Halvorsen, S James, P Jüni, V Kunadian, S Leonardi, R Mehran, G Montalescot, J Niebauer, S Price, RF Storey, H Völler, P Vranckx, S Windecker, M ValgimigliFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.